| 영문 | parenteral administration of drugs | 한글 | 비경구적 약품투여 |
|---|---|---|---|
| 설명 | 입을 통하지 않는 다양한 약품투여 방법을 말함. 주사기를 이용한다. 1)피하주사: subcutaneous injection-피부 밑으로 주사하는 것. 대개 팔의 중간부에 주사한다. 2)진피내주사: intradermal injection-얇게 찔러서 진피내에 주사한다. 주로 알러지 환자의 항원검사에 이용한다. 3)근육내주사: intramuscular injection-위팔이나, 혹은 엉덩이 부위에 주사한다. 이것은 주로 피부에 자극이 심한 약제나 혹은 천천히 작용하는 약제를 많이 주사할 때 사용한다. 4)혈관주사: intravenous(IV) injection-정맥을 통해 주사한다. 어느 정맥이나 가능하지만, 대개 팔뚝이나 발 등의 정맥을 이용한다. 빠른 치료효과를 보기 위해 사용한다. 이때 피부에 자극을 주는 약제이면, 새지 않도록 조심해야 한다. 5) 수막강내주사: intrathecal injection-두개나 척수강내에 주사할 때 이용한다. 6)강내주사: intracavitary injection-공간으로 된 부위에 주사한다. 예를 들어 복부공간이나 흉강내에 주사하여 사용한다. |
||
| 영문 | rectal administration of drugs | 한글 | 약물의 곧창자좌약식 투여 |
|---|---|---|---|
| 설명 | 입을 통해 먹은 약물은 흡수된 후 간을 거쳐 병변부위로 운반된다. 따라서 간에서 대사가 되어 약물로서의 효과가 없어질 가능성이 있을 뿐 아니라 간에 독성작용을 일으킬 수도 있다. 이러한 단점을 보완하기위해 간을 통하지 않고 재빨리 흡수되어 병변으로 갈 수 있는 방편으로 직장좌약을 사용한다. 직장의 정맥흐름은 간을 거치지 않고 직접 하대정맥을 통해 우심방으로 흘러들기 때문이다. |
||
| 영문 | side effects of drugs | 한글 | 약물의 부작용 |
|---|---|---|---|
| 설명 | 약을 사용할 때 기대하는 효과 외에 다른 장기에서 나타나는 원치 않는 효과를 총칭하는 말이다. 예를 들어 혈압을 낮추기 위해 항고혈압제를 사용 시, 혈압이 떨어지는 동시에 기관지의 수축이 일어나는 현상. |
||
| DO | Doctor of Osteopathy (one of two fully recognized medical practioners in the US-the other being MD);... |
|---|---|
| CEA | Carcino-Embryonic Antigen [HP 1825-6] ; Oncofetal Antigens ; Glycopro... |
| HIVD | Herniation(Herniated) of Inter-Vertebral Disc - Cervical HIVD &... |
| PEEP | Positive End-Expiratory Pressure ? Ix 1. PaO2 < 60 mmHg, ... |
| AL | absolute latency; acinar lumen; acute leukemia; adaptation level; albumin; alcoholism [and other dru... |
| ATD | Antithyroid drugs |
|---|---|
| DMARD | Disease Modifying Antirheumatic Drugs |
| NSAID | Non Steroid Anti-Inflammatory Drugs |
| SAARD | Slow Acting Anti-Rheumatic Drugs |
| DRO | Differential Reinforcement of Other Behaviour |
cactus grandiflorus
| other-directed | Pertaining to a person readily influenced by the attitudes of others. (05 Mar 2000) |
|---|---|
| transferases (other substituted phosphate groups) | <enzyme> A class of enzymes that transfers substituted phosphate groups. Registry number: EC 2.7.8 (12 Dec 1998) |
| antibiotics, antineoplastic | Chemical substances, produced by microorganisms, inhibiting or preventing the development of neoplasms. (12 Dec 1998) |
| antimetabolites, antineoplastic | Antimetabolites that are useful in cancer chemotherapy. (12 Dec 1998) |
| antineoplastic | Inhibiting or preventing the development of neoplasms, checking the maturation and proliferation of malignant cells. Origin: Gr. Plassein = to form (18 Nov 1997) |
| antineoplastic agent | Agents inhibiting or preventing the growth of neoplasms, checking the maturation and proliferation of malignant cells. (12 Dec 1998) |
| antineoplastic agent, alkylating | A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumour efficacy and the presence in their chemical structures of n-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumour cells are not completely understood. (12 Dec 1998) |
| antineoplastic agent, combined | The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. (12 Dec 1998) |
| antineoplastic agent, hormonal | Antineoplastic agent that are used to treat hormone-sensitive tumours. Hormone-sensitive tumours may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumour regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumours may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukaemias. (12 Dec 1998) |
| antineoplastic agent, phytogenic | Agents, obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (12 Dec 1998) |
| antineoplastic and immunosuppressive agents | Collective grouping for substances used to arrest the proliferation of malignant cells and those that suppress the immune response. (12 Dec 1998) |
| antineoplastic drug | A drug that stops or slows the maturation and spread of tumour cells (benign or malignant). (09 Oct 1997) |
| veterinary drugs | Drugs used by veterinarians in the treatment of animal diseases. The veterinarian's pharmacological armamentarium is the counterpart of drugs treating human diseases, with dosage and administration adjusted to the size, weight, disease, and idiosyncrasies of the species. In the united states most drugs are subject to federal regulations with special reference to the safety of drugs and residues in edible animal products. (12 Dec 1998) |
| cytotoxic drugs | <pharmacology> Anti-cancer drugs which act by killing or preventing the division of cells. See: chemotherapy. (13 Nov 1997) |
| psychotropic drugs | A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquillising agents (including the antipsychotics and anti-anxiety agents). (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|